Clinical Practice Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 105-115
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.105
Figure 2
Figure 2 Comparison of performance of the linear discriminant analysis metabonomic models, aspartate aminotransferase to platelet ratio index and fibrosis index based on four factors, in 69 chronic hepatitis C patients from Pernambuco/Brazil. A and C: Performance of metabonomic models (MM) and APRI to predict SF and C; B: Performance of MM and FIB-4 to predict advanced fibrosis. APRI: Aspartate aminotransferase to platelet ratio index; FIB-4: Fibrosis index based on four factors.